20 April 2023
Latham & Watkins Advises on Vaxcyte US$500 Million Public Offering
Advising firms
Deal team
11 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Shayne Kennedy Lead | Latham & Watkins LLP | Partner | capital markets | Orange County |
| Richard Kim | Latham & Watkins LLP | Partner | capital markets | Bay Area |
| Raul Gonzalez | Latham & Watkins LLP | Associate | capital markets | Not stated |
| Josh Landis | Latham & Watkins LLP | Associate | capital markets | Not stated |
| Rasha Suleiman | Latham & Watkins LLP | Associate | capital markets | Not stated |
| Betty Pang | Latham & Watkins LLP | Partner | regulatory matters | Bay Area |
| Chad Jennings | Latham & Watkins LLP | Counsel | regulatory matters | Washington, D. C. |
| Jekkie Kim | Latham & Watkins LLP | Partner | IP matters | Bay Area |
| Michael Sweeney | Latham & Watkins LLP | Associate | IP matters | Los Angeles |
| Kirt Switzer | Latham & Watkins LLP | Partner | tax matters | Bay Area |
| Derek Gumm | Latham & Watkins LLP | Associate | tax matters | Not stated |
Stated terms
- Stated value
- USD 500m (US$500 million)
- What the figure measures
- Issue size
- Client
- Not stated
- Counterparties
- Vaxcyte, Inc. (Issuer)